Bell’s palsy syndrome: Mimics and chameleons

Practical Neurology

Volumn 16, Issue 6, 2016, Pages 439-444

  Fuller, Geraint ^a   Morgan, Cathy ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID;

BELL PALSY; FACIAL NERVE PARALYSIS; HUMAN;

ADRENAL CORTEX HORMONES; ANTIVIRAL AGENTS; BELL PALSY; FACIAL PARALYSIS; HUMANS;

EID: 84997124399     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/practneurol-2016-001383     Document Type: Review

References (20)

1. Matthews WB. Practical Neurology. 3rd edn. London: Blackwell, 1975:159.
2. Croskey P. The importance of cognitive errors in diagnosis and strategies to minimize them. Acad Med 2003;78:775–80.
3. Eviston TJ, Croxson GR, Kennedy PGE, et al. Bell’s palsy: aetiology, clinical features and multidisciplinary care. J Neurol Neurosurg Psychiatr 2015;86:1356–61.
4. Gilden DH. Bell’s palsy. N Eng J Med 2004;351:1323–31.
5. Baugh RF, Basura GJ, Ishii LE, et al, Clinical Practice Guideline: Bell’s palsy. Otolaryngol Head Neck Surg 2013;149 (3 Suppl):S1–27.
6. Masterson L, Vallis M, Quinlivan R, et al. Assessment and management of facial nerve palsy. BMJ 2015;351:h3725.
7. Fuller GN. Bell’s palsy syndrome a name change to improve clinical reasoning. http://www.bmj.com/content/351/bmj.h3725/rr-1
8. Salinas RA, Alvarez G, Daly F, et al. Corticosteroids for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2010;(3):CD001942..CD001942.pub4
9. Gagyor I, Madhok VB, Daly F, et al. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2015;(11):CD001869.
10. Engström M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo- controlled multicentre trial. Lancet Neurol 2008;7:993–1000.
11. Peitersen E. Bell’s palsy: the spontaneous course of 2500 peripheral facial palsies of different etiologies. Acta Otolaryngol Suppl 2002;122:4–30.
12. De Seta D, Mancini P, Minni A, et al. Bell’s Palsy: symptoms preceding and accompanying the facial paresis. ScientificWorldJournal 2014;2014:801971.
13. Hohman MH, Hadlock TA. Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. Laryngoscope 2014;124:E283–94.
14. Gronseth GF, Paduga R. Evidence-based guideline update: steroids and antivirals for Bell Palsy, Report of the guideline development subcommittee of the American Academy of Neurology. Neurology 2012;79:2209–13.
15. Kawaguchi K, Inamura H, Abe Y, et al. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valaciclovir in patients with Bell’s palsy. Laryngoscope 2007;117:147–56.
16. Sweeney CJ, Gilden DH. Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry 2001;71:149–54.
17. Agarwal R, Manandhar L, Saluja P, et al. Pontine stroke presenting as isolated facial nerve palsy mimicking Bell’s palsy: a case report. J Med Case Rep 2011;5:287.
18. Morgan C, Fuller GN, Wakeley BR. Bifacial weakness with paraesthesias: serial nerve conduction studies indicate diffuse demyelinating neuropathy. Muscle Nerve Published Online First: 20. Jan 2016; doi:10.1002/mus.25028
19. Serran P, Hernandez N, Arroya JA, et al. Bilateral Bell Palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis 2007;44:e57–61.
20. Fuller G, Neurological examination made easy. 5th edn. Edinburgh: Churchill Livingstone, 2013.